Product Images Dipyridamole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Dipyridamole NDC 65841-664 by Zydus Lifesciences Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Dipyridamole Tablets, 25 mg - dipyridamoletablets figure 01

Dipyridamole Tablets, 25 mg - dipyridamoletablets figure 01

This is a product description for Dipyridamole tablets, USP-25. The dosage is specified as per the user space. The product is solely available with a prescription. The drug should be kept away out of reach from children. The package contains 100 tablets.*

Dipyridamole Tablets, 75 mg - dipyridamoletablets figure 03

Dipyridamole Tablets, 75 mg - dipyridamoletablets figure 03

This appears to be information about a medication called Dipyridamole Tablets USP, which are dispensed in a light-resistant container for protection. The dosage is typically 75mg and it is to be kept in a controlled room temperature environment. The lot number and manufacturer are also provided. More complete prescribing information is available, although it is not clear where to access this information.*

Dipyridamole Tablets, 50 mg - dipyridamoletablets figure 04

Dipyridamole Tablets, 50 mg - dipyridamoletablets figure 04

This appears to be a description of a medication called "Dipyridamole" available in 50 mg tablets. The NDC number is provided along with the recommended dosage information, although it is not clear whether the medication is intended for a specific condition or disease.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.